CTRI/2021/02/031353已完成3 期
A Prospective, Open Label, Three Arm, Controlled Study to Assess The Immune-Boosting Activity of Jeevaneeyam Tablets Plus Ojovardhini Capsule (Test Formulation A), Amrutha Sanjeevini Tablets plus Ojovardhini capsule (Test Formulation B) in mildly symptomatic COVID- 19 patients
Sri Sharada Ayurveda Pharmacy and RD Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects age group 18 - 70 years both gender
- •2.Patients diagnosed with COVID-19 positive mild symptomatic patients (Confirmed by RTPCR)
- •3.Patients with uncomplicated upper respiratory infection
- •a.Spo2 >94% in room air
- •b.Respiratory rate <24 per min
- •c.No evidence of hypoxaemia or breathlessness
- •4.Subjects willing to give a written informed consent and come for a regular follow up
- •5.Subject willing to abide by and comply with the study protocol
排除标准
- •1.Subjects below 18 and above 70 years of age
- •2.Presence of acute hypoxic respiratory failure.
- •3.Requiring Intensive care unit (ICU) stay.
- •4.Patients who need mechanical ventilation.
- •5.Category 6 or 5 based on modified 7-category ordinal scale of clinical status
研究者
相似试验
尚未招募
3 期
A clinical trial study of oral Roflumilast 0.5mg Tablet and combination therapy of Roflumilast 0.5 mg tablet plus Salmeterol 25mcg oral inhaler and combination therapy of Roflumilast 0.5 mg tablet plus Tiotropium 9mcg oral inhaler in adult patients with Chronic Obstructive Pulmonary Disease.CTRI/2014/01/004370MSN Laboratories Pvt Ltd300
尚未招募
4 期
A randomized clinical study to compare patient satisfaction and clinical outcome with three different nasal pack dressings available and that are used after nasal surgeryCTRI/2024/06/069152Dr Akhil Pratap Singh Trial Investigator
尚未招募
4 期
Efficacy, Safety, and Tolerability of Argin ED in the Treatment of Erectile Dysfunction in Elderly Diabetic PatientsCTRI/2024/05/067557Fourrts (India) Laboratories Pvt. Ltd.
已完成
不适用
A comparative Clinical Study to evaluate the safety and efficacy of polyherbal formulation in high lipid level and overweight population.CTRI/2016/01/006494Dabur India Limited110
进行中（未招募）
不适用
A MULTICENTER, THREE ARM, RANDOMIZED, OPEN LABEL CLINICAL STUDY TO COMPARE RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS RECEIVING AN IMMUNOSUPPRESSIVE REGIMEN OF ADVAGRAF® (IMMEDIATELY OR DELAYED POST-TRANSPLANT) AND MMF WITH OR WITHOUT A MONOCLONAL ANTI-IL2R ANTIBODY (BASILIXIMAB) - Short Title: DIAMOND StudyEUCTR2008-002231-32-HUAstellas Pharma Europe Ltd.900